Bariatric surgery significantly raises the risk of alcohol use disorder (AUD) and alcohol-related mortality, crucial for surgical decision-making. Gastric bypass (GBP) patients face a 5.07 times higher AUD risk, while vertical banded gastroplasty (VBG) and gastric banding patients are 2.28 and 2.34 times more likely to develop AUD, respectively. Alcohol-related mortality is 6.18 times higher […]

Metabolic bariatric surgery markedly enhances glycemic control and liver histology in patients with metabolic dysfunction-associated steatohepatitis (MASH). A scoping review of 14 studies reveals substantial reductions in fasting glucose, insulin resistance, and liver enzymes, alongside histological improvements, including decreased steatosis and fibrosis. These changes, observed over follow-up periods of 6 months to 5 years, underline […]

A meta-analysis of 38,647 gastric bypass patients across 27 countries reveals robotic Roux-en-Y gastric bypass (rrygb) requires longer surgical time but offers improved intraoperative safety compared to laparoscopic Roux-en-Y (lrygb). Despite a significant increase in robotic surgeries from 0.2% to 5.7% over 25 years, both techniques maintain similar mortality and complication rates. This comprehensive analysis […]

An international panel reached a consensus on sleeve gastrectomy, endorsing its use for diverse patient populations, including adolescents and the elderly. Key recommendations included avoiding routine dissection of the hiatus and prioritizing endoscopic pigtail drainage for managing acute leaks. Additional surgical options were outlined for patients with severe gastroesophageal reflux disease (GERD) and inadequate weight […]

One year post-bariatric surgery, 80% of patients showed a notable improvement in the nonalcoholic fatty liver disease (NAFLD) activity score. Nonalcoholic steatohepatitis (NASH) improved in 42.1% without worsening fibrosis, and 78.8% experienced fibrosis improvement. MRI-proton density fat fraction (MRI-PDFF) reliably detected liver fat remission in 72.2% to 90.4% of patients, while a significant decline in […]

Bariatric surgery has significantly enhanced safety, evidenced by a 40% reduction in 90-day mortality over 15 years and declining severe complications. Among 486,161 procedures, sleeve gastrectomy and gastric bypass remain prevalent. However, improvements have plateaued since 2018, signaling a need for fresh optimization strategies. Notably, postoperative medication use has shifted, with analgesic and antidepressant prescriptions […]

In a study involving 1,669 patients undergoing sleeve gastrectomy, staple-line leaks were significantly associated with low preoperative serum protein concentrations (spc). Patients with leaks had a median spc of 6.8 g/L compared to 7.1 g/L in those without leaks. Higher spc values reduced leak risk (odds ratio of 0.20). Additionally, major intraoperative bleeding and blood […]

In a comprehensive study of 5,221 adults with obesity and chronic kidney disease (CKD), bariatric metabolic surgery (BMS) demonstrated a significantly reduced risk of major adverse cardiovascular events, major adverse kidney events, and all-cause mortality over five years. The protective effects of BMS were consistent across all CKD stages but were notably stronger in patients […]

Bariatric surgery yields substantial economic benefits, with total healthcare costs for surgical patients decreasing by an average of $5,677 compared to nonsurgical counterparts within two years. The study examined 18,864 adults, revealing a 22.6% reduction in costs, particularly among those with type 2 diabetes, steatohepatitis, or aged 50-65, who experienced the highest savings. Findings underscore […]

Current findings highlight the efficacy of bariatric surgery in treating metabolic dysfunction-associated steatotic liver disease (MASLD) and its progression to steatohepatitis. The surgical interventions, including Roux-en-Y gastric bypass and sleeve gastrectomy, significantly enhance liver outcomes by reducing steatosis, inflammation, and fibrosis, while lowering cancer risk. These improvements are linked to changes in liver transcriptional programs […]